Story perspectives

UCSF's Revolutionary Test Promises Fast, Accurate Infection Diagnosis

2/25/2025

26 5

Summary

Story summary

UCSF researchers have pioneered a groundbreaking genomic test that utilizes metagenomic next-generation sequencing (mNGS) to swiftly diagnose infections by analyzing RNA and DNA from samples. This innovative approach can simultaneously detect multiple pathogens, promising to elevate diagnostic accuracy and enhance patient care while potentially lowering healthcare costs. Though not yet FDA-approved, it has earned breakthrough designation, signaling its transformative potential.

1 of 1

Story summary

UCSF researchers have pioneered a groundbreaking genomic test that utilizes metagenomic next-generation sequencing (mNGS) to swiftly diagnose infections by analyzing RNA and DNA from samples. This innovative approach can simultaneously detect multiple pathogens, promising to elevate diagnostic accuracy and enhance patient care while potentially lowering healthcare costs. Though not yet FDA-approved, it has earned breakthrough designation, signaling its transformative potential.